Glancy prongay & murray llp, a leading securities fraud law firm encourages west pharmaceutical services, inc. (wst) investors to inquire about securities fraud class action

Los angeles--(business wire)--glancy prongay & murray llp, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired west pharmaceutical services, inc. (“west” or the “company”) (nyse: wst) common stock between february 16, 2023 and february 12, 2025, inclusive (the “class period”). west investors have until july 7, 2025 to file a lead plaintiff motion. if you suffered a lo.
WST Ratings Summary
WST Quant Ranking